Other studies suggest that these mesenchymal-like cells can recapitulate the epithelial population of a tumor following chemotherapeutic therapy, potentially representing the HNSCC tumor equivalent to the CD44+/CD24− stem-like subpopulation in breast carcinomas [100,101,102]. This evidence concerns the gene CD44 and neoplasm.